Vanda Pharmaceuticals Inc. Income Statement

Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.00B0.04B0.03B0.03B0.03B0.05B0.11B0.15B0.17B0.19B0.23B0.25B0.27B0.25B0.19B0.20B
Cost of Revenue 0.00B0.00B0.00B0.00B0.02B0.02B0.02B0.02B0.02B0.02B0.03B0.02B0.01B0.01B
Gross Profit 0.00B0.03B0.03B0.05B0.09B0.12B0.15B0.17B0.20B0.22B0.24B0.23B0.18B0.19B
Operating items
Amortization - Intangibles 0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.01B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B
Depreciation & Amortization - Total 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Research & Development 0.03B0.05B0.03B0.02B0.03B0.03B0.04B0.04B0.05B0.06B0.08B0.09B0.08B0.07B
Selling, General & Administrative 0.02B0.01B0.01B0.01B0.03B0.08B0.08B0.10B0.12B0.11B0.13B0.14B0.12B0.14B0.11B0.15B
Other Operating Expenses 0.02B0.02B0.00B0.00B0.04B0.08B0.04B0.03B0.02B0.02B0.02B0.02B0.03B0.02B0.02B0.02B
Operating Expenses 0.04B0.03B0.04B0.06B0.06B0.03B0.15B0.16B0.18B0.17B0.20B0.22B0.23B0.25B0.21B0.24B
Operating Income -0.04B0.01B-0.01B-0.03B-0.02B0.02B-0.04B-0.02B-0.02B0.02B0.02B0.03B0.04B0.01B-0.01B-0.04B
EBIT -0.04B0.01B-0.01B-0.03B-0.02B0.02B-0.04B-0.02B-0.02B0.02B0.02B0.03B0.04B0.01B-0.01B-0.04B
Non-operating items
Interest & Investment Income 0.00B0.00B0.00B
Non Operating Income -0.00B0.00B
Net income details
EBT -0.04B0.01B-0.01B-0.03B-0.02B0.02B-0.04B-0.02B-0.02B0.03B0.03B0.03B0.04B0.01B0.01B-0.02B
Tax Provisions 0.00B-0.00B0.00B0.00B0.00B-0.09B0.01B0.01B0.01B0.00B-0.00B
Profit After Tax -0.04B0.01B-0.01B-0.03B-0.02B0.02B-0.04B-0.02B-0.02B0.03B0.12B0.02B0.03B0.01B0.00B-0.02B
Income from Continuing Operations -0.04B0.01B-0.01B-0.03B-0.02B0.02B-0.04B-0.02B-0.02B0.03B0.12B0.02B0.03B0.01B0.00B-0.02B
Consolidated Net Income -0.04B0.01B-0.01B-0.03B-0.02B0.02B-0.04B-0.02B-0.02B0.03B0.12B0.02B0.03B0.01B0.00B-0.02B
Income towards Parent Company -0.04B0.01B-0.01B-0.03B-0.02B0.02B-0.04B-0.02B-0.02B0.03B0.12B0.02B0.03B0.01B0.00B-0.02B
Net Income towards Common Stockholders 35,858.85B0.01B-0.01B-0.03B-0.02B0.02B-0.04B-0.02B-0.02B0.03B0.12B0.02B0.03B0.01B0.00B-0.02B
Additional items
EPS (Basic) -1.330.26-0.35-1.01-0.690.58-0.94-0.41-0.350.502.170.430.600.110.04-0.33
EPS (Weighted Average and Diluted) -1.330.25-0.35-1.01-0.690.55-0.94-0.41-0.350.482.110.420.580.110.04-0.33
Shares Outstanding (Weighted Average) 0.03B0.03B0.03B0.03B0.03B0.03B0.04B0.04B0.04B0.05B0.05B0.05B0.06B0.06B0.06B0.06B
Shares Outstanding (Diluted Average) 0.03B0.03B0.03B0.04B0.04B0.04B0.04B0.05B0.05B0.06B0.06B0.06B0.06B0.06B
EBITDA -0.04B0.01B-0.01B-0.03B-0.02B0.02B-0.04B-0.02B-0.02B0.02B0.02B0.03B0.04B0.01B-0.01B-0.04B
Tax Rate 26.03%11.23%0.54%26.28%21.74%44.47%60.42%17.54%